Wyeth v. Levine, 555 U.S. 555 (2009), is a United States Supreme Court case holding that Federal regulatory clearance of a medication does not shield the manufacturer from liability under state law. Contents. [hide]. 1 Facts. 1.1 Vermont jury trial; 1.2 Phenergan's regulatory background; 1.3 Wyeth's motion for judgment as a ...
Citation. Wyeth v. Levine, 555 U.S. 555, 129 S. Ct. 1187, 173 L. Ed. 2d 51, 2009 U.S. LEXIS 1774, 77 U.S.L.W. 4165, CCH Prod. Liab. Rep. P18,176, 21 Fla. L.
Syllabus. NOTE: Where it is feasible, a syllabus (headnote) will be released, as is being done in connection with this case, at the time the opinion is issued.The syllabus constitutes no part of the opinion of the Court but has been prepared by the Reporter of Decisions for the convenience of the reader.See United States v.
Mar 4, 2009 ... Diana Levine filed this personal injury action against Wyeth, the drug manufacturer, in state court in Vermont. Ms. Levine had intravenously injected Phenergan, a drug made by Wyeth and used to prevent allergies and motion sickness, into her arm, and complications arising from the injection eventually led ...